Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them. She also discusses the relatively slow pace of adoption of biosimilars in the U.S., the impact of innovative payment models on the marketplace, and the value that generics represent.
Video Forum: Christine Baeder, Teva USA
Latest
Walmart extends bet on exclusive brands with a hardware overhaul and its first new home line in five years
Retailer launches Greenworks Pro power tools and Mainstays Kids in a push to build loyalty through owned and exclusive assortments
Save A Lot releases 2025 Business and Social Impact Report
Report highlights Save A Lot’s investment in communities, operational growth, customer access and team member development
General Mills and its iconic brands celebrate America’s 250th birthday with 79 themed products
From nostalgic treats to celebratory favorites, the lineup brings red, white and blue fun to breakfast, lunch and dinner – and all the moments in between this summer
Dollar Tree tops estimates in strong first quarter, touting value edge amid cautious consumer climate
Retailer posts 38% increase in adjusted EPS, expands multi-price format to nearly 5,900 stores in 40th anniversary year